Related Experiment Video
Updated: Aug 15, 2026

Adaptation of Semiautomated Circulating Tumor Cell (CTC) Assays for Clinical and Preclinical Research Applications
Published on: February 28, 2014
[The costs of cancer screening (author's transl)]
Abstract:
By the cancer screening programme of the German legal health insurance 4,830,717 females were examined in 1973. The yield of cytologic "positive" cases has been 0.23 percent. The sum for finding one of these cases has been in the range from 14,388.-- DM to 16,132.--DM. As can be calculated by the available data on the incidence of cancer of the cervix uteri only about one third of these cases with "positive" findings can be a proven case of cancer (carcinoma in situ included). Thus one proven carcinoma of this site can be detected by the costs of 40,656.--DM to 80,586.--DM and this sum shows an increasing tendency. In spite of these high costs for the cancer detection programme the total expenses for early detection measures amounted only to 0.6 percent of the total expenditues of the legal health insurance in the first half-year 1974. The problem of a high rate of false-positive smears is discussed.
Related Concept Videos
Cancer
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer Survival Analysis

